Subcutaneous rituximab given to patients for other indications than CD20+ B-cell lymphoma: A monocentric study of 20 cases
Sign Up to like & getrecommendations! Published in 2018 at "Leukemia Research Reports"
DOI: 10.1016/j.lrr.2018.01.002
Abstract: Rituximab (R) (Rituxan®, Roche, Basel Switzerland) is the first antiCD20 monoclonal antibody that has demonstrated efficacy in patients with various lymphoid malignancies, including indolent and aggressive forms of B-cell non-Hodgkin's lymphoma and B-cell chronic lymphocytic… read more here.
Keywords: lymphoma; given patients; patients indications; indications cd20 ... See more keywords
Doctor, can I drive? A quality improvement project to improve driving advice given to patients in our cardiology unit.
Sign Up to like & getrecommendations! Published in 2019 at "Clinical medicine"
DOI: 10.7861/clinmedicine.19-3-s68
Abstract: Many cardiac conditions confer a restriction on driving as laid out by the Driver and Vehicle Licensing Agency (DVLA).[1][1] As doctors, it is our duty to ensure that patients are correctly informed of these restrictions.[2][2]… read more here.
Keywords: doctor drive; quality improvement; cardiology; improvement project ... See more keywords